Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,556.00
Bid: 12,548.00
Ask: 12,550.00
Change: 6.00 (0.05%)
Spread: 2.00 (0.016%)
Open: 12,570.00
High: 12,704.00
Low: 12,472.00
Prev. Close: 12,550.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks close higher on Wall St, airlines bounce

Thu, 28th Jan 2021 09:16

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Airlines gain on short squeeze in AAL

* EU warns it could block vaccine exports

* Spike in volatility hits equities
(Updates to market close)

By Sruthi Shankar and Joice Alves

Jan 28 (Reuters) - European stocks closed higher on Thursday
as a bounce in Wall Street stocks, gains in airlines and upbeat
earnings reports drove a reversal of early losses across
markets.

After falling as much as 2% in morning trade, the
pan-European STOXX 600 rose 0.1% by the close, leaving
the benchmark with small gains for the year.

The German DAX gained 0.3%, France's CAC 40
was up 0.9% and Britain's exporter-heavy FTSE fell 0.6%,
coming under pressure from a rise in the pound.

Stocks globally saw a spike in volatility this week as a
retail trading frenzy hit markets in the United States, Europe
and Asia, inflating value in certain stocks that major hedge
funds have bet against.

Wall Street jumped on gains in technology stocks, while
American Airlines surged more than 20% at one point
after the U.S. carrier was mentioned on Reddit's WallStreetBets
forum following its results.

European travel names like Lufthansa, TUI
and British Airways-owner IAG rose between 4.7% and
7.2%. Wizz Air and easyJet rose more than 4.5%
each despite posting a double-digit decline in fourth-quarter
revenue.

"UK airlines are tracking a short squeeze in American
Airlines brought on by r/WallStreetBets after it released Q4
earnings," said Jasper Lawler, head of research at LCG. "AA has
abnormally high short interest but other airlines do too given
the state the industry is in."

Other European stocks that were highly bid this week, like
CD Projekt, Ambu and Varta,
extended gains, while Nokia tumbled 13%.

Investors looked past strong earnings from Apple
and Facebook as well as the U.S. Federal Reserve's pledge
to stick to loose monetary policy as worries about slow rollout
of COVID-19 vaccines and more curbs in Europe dampened the mood.

"With valuations at levels already pricing in much of the
recovery from a pandemic that is far from over, these
corrections are always possible," Ian Williams, economics and
strategy research analyst at Peel Hunt said in a note.

Germany is preparing entry restrictions for travellers from
Britain, Brazil and South Africa, and its health minister
expects the current shortage of coronavirus vaccines to continue
well into April.

Meanwhile, the European Union warned drug companies such as
AstraZeneca that it would use all legal means or even
block exports unless they agreed to deliver shots as promised.

The world's largest spirits maker Diageo rose 3%
after it reported a surprise rise in underlying net sales growth
in the first half of the year, helped by strong U.S. demand.

Swedish medical equipment maker Getinge jumped 9%
after reporting strong quarterly results as it saw a spike in
demand in 2020 for ventilators and other advanced life support
equipment due to the pandemic.
(Reporting by Sruthi Shankar in Bengaluru and Joice Alves in
London; Editing by Arun Koyyur and Mark Heinrich)

More News
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more
22 Sep 2023 07:27

AstraZeneca reports positive findings from breast cancer threatment trial

(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.

Read more
20 Sep 2023 08:44

TOP NEWS: AstraZeneca's rare disease business buys Pfizer portfolio

(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.

Read more
15 Sep 2023 15:27

AstraZeneca and Daiichi Sankyo's Enhertu recommended for approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.

Read more
14 Sep 2023 08:25

Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board

(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.

Read more
11 Sep 2023 21:54

AstraZeneca says Fasenra therapy meets primary endpoint at trial

(Alliance News) - AstraZeneca PLC on Monday said that its therapy, Fasenra, met the primary endpoint in the Mandara phase three trial in eosinophilic granulomatosis with polyangiitis.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.